Ambrx Biopharma Cayman, Inc. Entity Common Stock, Shares Outstanding 2021 - 2023

Historical data

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from 2021 to 2023.
  • Ambrx Biopharma Cayman, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 7, 2023 was 434 M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 434 M Aug 7, 2023 10-Q 2023-08-09
Q1 2023 386 M Mar 24, 2023 10-K 2023-03-30
Q4 2021 300 M Dec 31, 2021 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.